Clinical Trials Logo

Dengue With Warning Signs clinical trials

View clinical trials related to Dengue With Warning Signs.

Filter by:
  • None
  • Page 1

NCT ID: NCT05611710 Recruiting - Dengue Clinical Trials

Anakinra in Dengue With Hyperinflammation ( AnaDen )

Start date: January 2, 2023
Phase: Phase 2
Study type: Interventional

This study aims to evaluate the effect of anakinra in dengue patients with hyperinflammation as compared to placebo Primary Objective: To evaluate the efficacy of Anakinra in moderate-severe dengue patients with hyperinflammation. Secondary Objectives: - To assess the safety of anakinra therapy in dengue with hyperinflammation - To assess the effect of anakinra therapy in patients with dengue on physiological, clinical and virological parameters - To assess the immunomodulation effects of anakinra in dengue - Immune cell signatures in dengue with and without anakinra - To assess difference in gene expression between treatment group compared to non-treatment population

NCT ID: NCT04673422 Completed - Dengue Clinical Trials

Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients

Start date: January 15, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

This study aims to determine the efficacy of montelukast in reducing the incidence of dengue warning signs in adult dengue patients.